A Randomized, Controlled, Parallel Group, Patient-blinded, Single-center, Phase I Pilot Study to Assess the Tolerability and Safety of Repeated Administrations of a Single-dose of AFFITOPE AD03 to Alzheimer's Disease Patients.

Trial Profile

A Randomized, Controlled, Parallel Group, Patient-blinded, Single-center, Phase I Pilot Study to Assess the Tolerability and Safety of Repeated Administrations of a Single-dose of AFFITOPE AD03 to Alzheimer's Disease Patients.

Completed
Phase of Trial: Phase I

Latest Information Update: 19 Dec 2011

At a glance

  • Drugs Affitope AD03 (Primary) ; Alum
  • Indications Alzheimer's disease
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms MimoVax
  • Sponsors AFFiRiS
  • Most Recent Events

    • 19 Dec 2011 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.
    • 19 Dec 2011 Actual patient number (28) added as reported by ClinicalTrials.gov.
    • 19 Dec 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top